These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31539289)

  • 1. Comparison of autoinjector with accessorized prefilled syringe for benralizumab pharmacokinetic exposure: AMES trial results.
    Martin UJ; Fuhr R; Forte P; Barker P; Axley MJ; Aurivillius M; Yan L; Roskos L
    J Asthma; 2021 Jan; 58(1):93-101. PubMed ID: 31539289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tezepelumab Pharmacokinetics, Safety, and Tolerability After Administration via Vial-and-syringe, Accessorized Prefilled Syringe, or Autoinjector: A Randomized Trial in Healthy Volunteers.
    Zheng Y; Abuqayyas L; Megally A; Fuhr R; Sałapa K; Downie J; Colice G
    Clin Ther; 2021 Jan; 43(1):142-155.e5. PubMed ID: 33380362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results.
    Ferguson GT; Cole J; Aurivillius M; Roussel P; Barker P; Martin UJ;
    J Asthma Allergy; 2019; 12():363-373. PubMed ID: 31695439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and Pharmacodynamic Bioequivalence of Pegfilgrastim-cbqv Delivered via a Prefilled Autoinjector and Prefilled Syringe in Healthy Male Participants.
    Tang H; Civoli F; Tatarewicz S; Vandenkoornhuyse N; Finck B
    Adv Ther; 2023 Nov; 40(11):4889-4906. PubMed ID: 37707674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults.
    Tomaszewska-Kiecana M; Dryja A; Ullmann M; Petit-Frere C; Illes A; Dagres C; Monnet J
    Expert Rev Clin Immunol; 2023 Apr; 19(4):447-455. PubMed ID: 36789991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionality and Performance of an Accessorized Pre-Filled Syringe and an Autoinjector for At-Home Administration of Tezepelumab in Patients with Severe, Uncontrolled Asthma.
    Alpizar S; Megally A; Chen C; Raj A; Downie J; Colice G
    J Asthma Allergy; 2021; 14():381-392. PubMed ID: 33907423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers.
    Zhang W; Tyrrell H; Ding HT; Pulley J; Boruvka A; Erickson R; Abouhossein M; Ravanello R; Tang MT
    Adv Ther; 2021 May; 38(5):2418-2434. PubMed ID: 33778929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma.
    Ferguson GT; Mansur AH; Jacobs JS; Hebert J; Clawson C; Tao W; Wu Y; Goldman M
    J Asthma Allergy; 2018; 11():63-72. PubMed ID: 29670379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects.
    Struemper H; Murtaugh T; Gilbert J; Barton ME; Fire J; Groark J; Fox NL; Roth D; Gordon D
    Clin Pharmacol Drug Dev; 2016 May; 5(3):208-15. PubMed ID: 27163500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence Between a New Omalizumab Prefilled Syringe With an Autoinjector or with a Needle Safety Device Compared with the Current Prefilled Syringe: A Randomized Controlled Trial in Healthy Volunteers.
    Sangana R; Xu Y; Shah B; Tian X; Zack J; Shakeri-Nejad K; Kalluri S; Jones I; Ligueros-Saylan M; Taylor AF; Jain DK; Scosyrev E; Uddin A; Laurent N; Paganoni P
    Clin Pharmacol Drug Dev; 2024 Jun; 13(6):611-620. PubMed ID: 38389387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 3, open-label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate-to-severe plaque psoriasis (UNCOVER-A).
    Callis Duffin K; Bagel J; Bukhalo M; Mercado Clement IJ; Choi SL; Zhao F; Gill A; Pangallo B; Shuler C; Mallbris L; Jackson K
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):107-113. PubMed ID: 27500949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe.
    Cohen YZ; Zhang X; Xia B; Kosloski MP; Kamal MA; Davis JD; Kanamaluru V; Xu C
    Clin Pharmacol Drug Dev; 2022 May; 11(5):675-681. PubMed ID: 35278283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetics and Pharmacodynamics of Benralizumab in Healthy Volunteers and Patients With Asthma.
    Wang B; Yan L; Yao Z; Roskos LK
    CPT Pharmacometrics Syst Pharmacol; 2017 Apr; 6(4):249-257. PubMed ID: 28109128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence of Canakinumab Injected Subcutaneously via an Autoinjector Device or a Prefilled Safety Syringe Device in Healthy Subjects.
    Anumolu SS; Lindgren S; Vemula J; Floch D; Reynolds C; Wallny HJ; Sun H
    Clin Pharmacol Drug Dev; 2018 Nov; 7(8):829-836. PubMed ID: 29676864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute Bioavailability and Pharmacokinetic Comparability of Sirukumab Following Subcutaneous Administration by a Prefilled Syringe or an Autoinjector.
    Zhuang Y; de Vries DE; Marciniak SJ; Liu H; Zhou H; Davis HM; Leon F; Raible D; Xu Z
    Clin Pharmacol Drug Dev; 2017 Nov; 6(6):570-576. PubMed ID: 28052588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetic Modeling of Benralizumab in Adult and Adolescent Patients with Asthma.
    Yan L; Wang B; Chia YL; Roskos LK
    Clin Pharmacokinet; 2019 Jul; 58(7):943-958. PubMed ID: 30854591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pharmacokinetics and Relative Bioavailability of Mepolizumab 100 mg Liquid Formulation Administered Subcutaneously to Healthy Participants: A Randomized Trial.
    Shabbir S; Pouliquen IJ; Bentley JH; Bradford ES; C Kaisermann M; Albayaty M
    Clin Pharmacol Drug Dev; 2020 Apr; 9(3):375-385. PubMed ID: 31317668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of Subcutaneous Itepekimab Injection With an Autoinjector Device and Prefilled Syringe in Healthy Participants.
    Xu C; Xin K; Kosloski MP; Butler A; Goulaouic H; Nivens MC; Kanamaluru V
    Clin Pharmacol Drug Dev; 2024 Nov; 13(11):1181-1188. PubMed ID: 39308293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Ferguson GT; FitzGerald JM; Bleecker ER; Laviolette M; Bernstein D; LaForce C; Mansfield L; Barker P; Wu Y; Jison M; Goldman M;
    Lancet Respir Med; 2017 Jul; 5(7):568-576. PubMed ID: 28545978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usability of mepolizumab single-use prefilled autoinjector for patient self-administration.
    Bernstein D; Pavord ID; Chapman KR; Follows R; Bentley JH; Pouliquen I; Bradford E
    J Asthma; 2020 Sep; 57(9):987-998. PubMed ID: 31251090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.